Kristen Peck, who helped orchestrate the Wyeth merger, will replace the retiring William Ringo as head of worldwide biz dev.
Merge Healthcare's $6.05-per-share offer was turned away by Amicas' board, though the target's stock price is trading higher.
Increasingly, private equity firms have targeted payment processors for dealmaking opportunities.
The electronics makers US arm makes an investment in iCyt, a producer of stem cell research equipment.
The buyout firm will provide $25 million in debtor-in-possession financing.
Henry Schein's Mark Mlotek takes a simple but effective approach in assessing compatibility and alignment.
Diversity is making a comeback, but dealmakers are following a recipe.
Our latest roundtable explores how the market for intellectual property has changed amid the downturn.
Does the enthusiasm for healthcare overlook some of the sector's looming questions?
Mid-market dealmakers are optimistic the consolidation in the large market will trickle down.